BioStomyProject reference: 662932
Funded under :
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
Development of manufacturing process for a novel multi-layer film comprising of a water-soluble polymer and a bio-compostable polymer to enable flushable ostomy pouches
Total cost:EUR 71 429
EU contribution:EUR 50 000
Coordinated in:United Kingdom
Topic(s):NMP-25-2014-1 - Accelerating the uptake of nanotechnologies, advanced materials or advanced manufacturing and processing technologies by SMEs
Call for proposal:H2020-SMEINST-1-2014See other projects for this call
Funding scheme:SME-1 - SME instrument phase 1
Ostomy drainage pouches are medical devices made of heavy-duty plastic used to collect waste from a surgically diverted colon, ileum or urinary system. Unfortunately, their disposal can cause users psychological, social, and work-related problems, negatively affecting their quality of life. Soiled ostomy devices become domestic waste and the heavy-duty plastic is non-bio-compostable and so ends up at landfill sites with over 850 million ostomy pouches disposed in landfills annually across the EU representing more than 100,000 tonnes of liquid and plastic waste.
BioStomy seeks to address challenges faced by ostomy pouch users, by providing an industry first, fully flushable ostomy pouch, enabled through the combined use of advanced water soluble and biodegradable material and a novel advanced manufacturing process involving a single co-extrusion of these materials and an adhesive layer.
We anticipate that over a period of five years, we will be able to replace 5.49 million pouches making a profit of €23.79 million and saving over 600 tonnes of plastic waste from landfills. Eucomed estimates that about 0.14% of the total population (700,000 citizens) in the EU has an ostomy and so BioStomy addresses Europe’s challenges of an increasingly ageing society and reducing waste by providing an innovative, ostomy pouching system that is environmentally friendly and convenient for users.
In the Phase 1, we intend to investigate the dynamics of the co-extrusion process, study the market and investigate potential alternative applications for our product.
The aim of Phase 2 will be to reduce the thickness of our novel multi-layer material so as to reduce cost and increase usability and manufacturability. Secondly, to prototype and validate a high volume advanced manufacturing process using a single multi-layer differentiated co-extrusion to produce the prescribed film.
EU contribution: EUR 50 000
5 LEYS AVENUE
SG63EA LETCHWORTH GARDEN CITY